Index in nutrition assessment, 2, 3, 3b
infections, catheter-related in central venous catheters, 16–17, 25–27, 105, 105b in home parenteral nutrition, 26, 27, 105, 105b
liver disease in, 76b
infusion schedule in home parenteral nutrition, 94–95, 109 initiation of parenteral nutrition, 8, 8b, 58 insulin therapy, 60–61, 62b, 79 continuous infusion in, 61, 62b correctional (sliding) scale, 61, 62b in home parenteral nutrition, 94, 95–96, 96t
insurance reimbursement. See reimbursement for home parenteral nutrition intake/output monitoring, 94 intradialytic parenteral nutrition, 9 intravenous lipid emulsions, 34–36 adverse reactions to, 35–36, 61, 63–64, 64b allergic reactions to, 35–36, 69 calories in, 34, 35t, 49, 60, 61 contraindications to, 35–36 in formula prescription calculations, 49b
hypertriglyceridemia from, 61, 63, 79–80 and liver disease, 75 in long-term parenteral nutrition, 82b, 84b oil mixture in, 34, 35t, 63, 75, 84b in 3-in-1 preparations, 47b, 48, 48b, 49b in 2-in-1 preparations, 46, 49b
iron, 57t, 80–81, 108b
jugular veins as access site, 14, 15f, 17, 19b
macronutrients, 31–36 in advancing parenteral nutrition, 58, 59b in home parenteral nutrition, 92b, 94 and liver disease, 68, 68b, 75, 75b
kidney disorders, 9, 33–34 Klebsiella pneumoniae infections, 27
magnesium, 39–40 daily requirements for, 36b in home parenteral nutrition, 101, 104b, 108b
in hypomagnesemia. See hypomagnesemia in initiation of parenteral nutrition, 8b
laboratory tests laboratory monitoring of, 57t
in home parenteral nutrition, 107, 108b in initiation of parenteral nutrition, 8b, 58 in monitoring parenteral nutrition, 56, 57t, 107, 108b in nutrition assessment, 56
lifestyle factors in home parenteral nutrition, 93, 94–95, 109 in metabolic bone disease, 77, 78b in quality of life, 109 reducing risk of complications, 84b linoleic acid, 34, 63 linolenic acid, 34, 63 lipid emulsions, intravenous. See intravenous lipid emulsions
liver disease, parenteral nutrition- associated, 67–68, 73–75 etiologies of, 68, 74, 74b in home parenteral nutrition, 94 in long-term parenteral nutrition, 73–75 macronutrients in, 68, 68b, 75, 75b micronutrients in, 75, 76b non-nutrient factors in, 75, 76b–77b prevention of, 68b, 75b–77b
liver failure, specialized amino acid formulas in, 33 long-term acute care hospitals, 87, 90 long-term parenteral nutrition central vascular access devices in, 17 complications of, 73–84, 111 definition of, 73
lysine, 44, 76b
129
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149